MS4A1-eiwit (C-His, Cynomolgus)

MS4A1

C-His

< 1.0 EU per μg protein as determined by the LAL method.

1.Immobilized Recombinant Cynomolgus CD20 Protein (VLP, Full-Length, His Tag) (Cat: 90052-C08H1) at 5 μg/mL (100 μL/well) can bind Obinutuzumab derived Anti-CD20 antibody, Human IgG1, the EC50 is 5-20 ng/mL (QC tested) . 2.Immobilized Recombinant Cynomolgus CD20 Protein (VLP, Full-Length, His Tag) (Cat: 90052-C08H1) at 5 μg/mL (100 μL/well) can bind Ofatuzumab derived Anti-CD20 antibody, Human IgG1, the EC50 is 10-40 ng/mL (Routinely tested) . 3.Immobilized Recombinant Cynomolgus CD20 Protein (VLP, Full-Length, His Tag) (Cat: 90052-C08H1) at 5 μg/mL (100 μL/well) can bind Rituximab derived Anti-CD20 antibody, Human IgG1, the EC50 is 20-60 ng/mL (Routinely tested) .

Met1-Pro297

The recombinant Cynomolgus MS4A1-VLP consists of 312 amino acids and predicts a molecular mass of 34.73 kDa.

Cynomolgus